Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Hoefsloot

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
BMC Infectious Diseases|May 5, 2018
High mortality in patients with Mycobacterium avium complex lung disease: a systematic reviewRoland Diel, Marc Lipman, Wouter Hoefsloot
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2009
Quiz page March 2009: A 58-year-old man with chronic hepatitis B, nephrotic syndrome, and a papulosquamous rashWouter Hoefsloot, Louis Reichert, Jos Meijer, et al.
The European Respiratory Journal|May 2, 2024
Rifampicin has no role in treatment of <i>Mycobacterium avium</i> complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpointJakko van Ingen, Wouter Hoefsloot, Véronique Dartois, et al.
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic ReviewSanne M H Zweijpfenning, Jakko van Ingen, Wouter Hoefsloot
Expert Opinion on Pharmacotherapy|July 22, 2021
The role of amikacin in the treatment of nontuberculous mycobacterial diseaseJelmer Raaijmakers, Jodie Anne Schildkraut, Wouter Hoefsloot, et al.
European Journal of Applied Physiology|August 9, 2003
Relative contributions of central and peripheral factors to fatigue during a maximal sustained effortMaartje L Schillings, Wouter Hoefsloot, Dick F Stegeman, et al.
ERJ Open Research|December 10, 2025
Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?Arthur Lemson, Esmee van der Pol, Jakko van Ingen, et al.
Respiration; International Review of Thoracic Diseases|March 30, 2025
A Unique Combination of Heterozygous CFTR Gene Variants in a Person with Cystic Fibrosis and Mycobacterium abscessus InfectionArthur Lemson, Cedric Bosteels, Jakko van Ingen, et al.
Respiratory Medicine|July 22, 2023
Monotherapy: Key cause of macrolide-resistant Mycobacterium avium complex diseaseDaniel Loewenstein, Lars van Balveren, Arthur Lemson, et al.
Expert Review of Anti-Infective Therapy|October 16, 2013
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidenceJakko van Ingen, Beatriz E Ferro, Wouter Hoefsloot, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|May 5, 2018
High mortality in patients with Mycobacterium avium complex lung disease: a systematic reviewRoland Diel, Marc Lipman, Wouter Hoefsloot
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2009
Quiz page March 2009: A 58-year-old man with chronic hepatitis B, nephrotic syndrome, and a papulosquamous rashWouter Hoefsloot, Louis Reichert, Jos Meijer, et al.
The European Respiratory Journal|May 2, 2024
Rifampicin has no role in treatment of <i>Mycobacterium avium</i> complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpointJakko van Ingen, Wouter Hoefsloot, Véronique Dartois, et al.
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic ReviewSanne M H Zweijpfenning, Jakko van Ingen, Wouter Hoefsloot
Expert Opinion on Pharmacotherapy|July 22, 2021
The role of amikacin in the treatment of nontuberculous mycobacterial diseaseJelmer Raaijmakers, Jodie Anne Schildkraut, Wouter Hoefsloot, et al.
European Journal of Applied Physiology|August 9, 2003
Relative contributions of central and peripheral factors to fatigue during a maximal sustained effortMaartje L Schillings, Wouter Hoefsloot, Dick F Stegeman, et al.
ERJ Open Research|December 10, 2025
Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?Arthur Lemson, Esmee van der Pol, Jakko van Ingen, et al.
Respiration; International Review of Thoracic Diseases|March 30, 2025
A Unique Combination of Heterozygous CFTR Gene Variants in a Person with Cystic Fibrosis and Mycobacterium abscessus InfectionArthur Lemson, Cedric Bosteels, Jakko van Ingen, et al.
Respiratory Medicine|July 22, 2023
Monotherapy: Key cause of macrolide-resistant Mycobacterium avium complex diseaseDaniel Loewenstein, Lars van Balveren, Arthur Lemson, et al.
Expert Review of Anti-Infective Therapy|October 16, 2013
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidenceJakko van Ingen, Beatriz E Ferro, Wouter Hoefsloot, et al.
Pageof 8